Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Gilead Sciences balance Sheet — Total assets ($M) ($M)
Form 10-Q / 10-K Consolidated Balance Sheets (DB)
Latest, FY2025
59,023
Period ended Dec 31, 2025
Change on a year earlier
0.0%
58,995 in FY2024
History
18 years
Since FY2008
Sources
17
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Balance Sheet — Total assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 59,023 | 0.0% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 58,995 | -5.0% | Form 10-K (filed 2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 62,125 | -1.7% | Form 10-K (filed 2024-02-23) ↗ |
| FY2022 | Dec 31, 2022 | 63,171 | -7.0% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 67,952 | -0.7% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 68,407 | +11.0% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 61,627 | -3.2% | Form 10-K (filed 2020-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 63,675 | -9.4% | Form 10-K (filed 2019-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 70,283 | +23.4% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 56,977 | +10.2% | Form 10-K (filed 2017-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 51,716 | +49.2% | Form 10-Q (filed 2016-05-06) ↗ |
| FY2014 | Dec 31, 2014 | 34,664 | +53.5% | Form 10-K (filed 2015-02-25) ↗ |
| FY2013 | Dec 31, 2013 | 22,579 | +6.3% | Form 10-K (filed 2015-02-25) ↗ |
| FY2012 | Dec 31, 2012 | 21,240 | +22.8% | Form 10-K (filed 2013-02-27) ↗ |
| FY2011 | Dec 31, 2011 | 17,303 | +49.3% | Form 10-K (filed 2012-02-23) ↗ |
| FY2010 | Dec 31, 2010 | 11,593 | +19.5% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 9,699 | +39.8% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | 6,937 | – | Form 10-Q (filed 2009-08-05) ↗ |
Breakdown
What makes up balance sheet — total assets ($m)
- Accounts receivable, net ($M)4,913 · FY2025
- Inventories ($M)1,774 · FY2025
- Total current assets ($M)18,342 · FY2025
- Property, plant and equipment, net ($M)5,606 · FY2025
- Goodwill ($M)8,314 · FY2025
- Intangible assets, net ($M)16,978 · FY2025
- Total current liabilities ($M)11,813 · FY2025
- Long-term debt, noncurrent ($M)22,129 · FY2025
- Retained earnings ($M)13,730 · FY2025
- Total stockholders' equity ($M)22,618 · FY2025
Cite this data
StockData. (2026). Gilead Sciences Balance Sheet — Total assets ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_balance_sheet
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.